secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2021-10-15T23:59:59+00:00
Accession:  0001104659-21-126763
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Johan Christenson resigns from Aprea Therapeutics board
----------------------------------------------------------------

- Johan Christenson, M.D., Ph.D. resigned from the Board of Directors effective upon filing of Q3 2021 Form 10-Q.
- Resignation is not due to any disagreement with the company's operations, policies, or practices.
- No replacement director has been announced yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000110465921126763/0001104659-21-126763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000110465921126763/tm2130064d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-126763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer